FUTUREBIOTICS IPO SEEKS TO RAISE $2 MIL FOR ACQUISITIONS
This article was originally published in The Tan Sheet
Executive Summary
FUTUREBIOTICS IPO SEEKS TO RAISE $2 MIL FOR ACQUISITIONS and product development, according to an April 21 prospectus covering the spin-off of Futurebiotics by parent company PDK Labs. Futurebiotics hopes to raise $6 mil. from the offering of 1.2 mil. units -- which include one unit of common stock and one warrant -- at $5 per unit. The company has earmarked $1.9 mil. of the proceeds to cover working capital for approximately 12 months.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning